Financials

  • Market Capitalization 652.72 M
  • Employee 191
  • Founded 2006
  • CEO N/A
  • Website www.cormedix.com
  • Headquarter Delaware, United States
  • FIGI BBG000Q4BQK0
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
3.13
Rapporto prezzo/fatturato
0

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
2728
ALLO
Allogene Therapeutics, Inc. - Common Stock
1.93 USD-3.50%-8.10%0.00%+49.61%666.15 M USD
2740
RGNX
REGENXBIO Inc. - Common Stock
12.75 USD-8.60%-14.03%+87.78%-5.06%659.14 M USD
2748
TECX
Tectonic Therapeutic, Inc. - Common Stock
34.34 USD-0.09%-2.75%+12.00%+100.23%647.97 M USD
2761
PRME
Prime Medicine, Inc. - Common Stock
3.52 USD-6.88%-13.30%+20.55%-27.42%635.77 M USD

Notizie